Laryngeal Cancer Cells Metabolize 25-Hydroxyvitamin D3 and Respond to 24R,25-dihydroxyvitamin D3 via a Mechanism Dependent on Estrogen Receptor Levels. - Dennis CD; Dillon JT; Patel PH; Cohen DJ; Halquist MS; Pearcy AC; Boyan BD; Schwartz Z (Cancers, 2024)